Juliet Thompson

The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths liein diagnostics product development, commercialisation, contract design and manufacturing. The Company’s lead business units comprise of Primerdesign andLab21 Products,supplying an extensive range of high quality assays and reagents worldwide. The Group directly serves oncology, microbiology, haematology andserology markets as do its global partners, which include major corporates.